| Prechel, Helmut (Biozym Scientific 200512) |
n. a. |
Biozym (DE) (Group) |
Germany |
| Precht, Engelbert (Medigenomix 200809 and BIO Deutschland) |
Managing Director |
Eurofins (Group) |
Germany |
| Prehn, Guido (DPE Deusche Private Equity 201706 Partner) |
Partner (venture partner) |
DPE Deutsche Private Equity GmbH |
Germany |
| Prescher, Horst (SialoTec GmbH 201601– Managing Director) |
Managing Director |
SialoTec GmbH |
Germany |
| Preston, David (Boehringer Ingelheim 201112 CEO of Boehringer Ingelheim China) |
Chief Executive Officer (CEO) |
Boehringer Ingelheim (Group) |
China |
| Preti, Robert A. (Hitachi 201901 CEO Hitachi Chemical Advanced Therapeutics Solutions + General Manager RegMed business) |
Chief Executive Officer (CEO) |
Showa Denko (SDK) (Group) |
United States (USA) |
| Pretsell, Douglas (Northbank Communications Munich 200508) |
Public Relations Manager / Investor Relations Manager |
Instinctif Partners (Group) |
Germany |
| Price, Fredric D. (Chiasma 201302 CEO) |
Chief Executive Officer (CEO) |
Chiasma (Group) |
United States (USA) |
| Prieels, Jean-Paul (Themis Bioscience 201505– Board Member former SVP RnD at GSK Biologicals) |
Board member, non-executive |
Merck (US) (MSD) (Group) |
Austria |
| Prieschl-Grassauer, Eva (Marinomed Biotechnologie GmbH 201307 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Marinomed Biotech AG (VSE: MARI) |
Austria |
| Prikazsky, Marc (CEVA 201203 CEO) |
Chief Executive Officer (CEO) |
CEVA (Group) |
France |
| Prince, William T. (Nabriva 200811– CMO before Surface Logix 200510 Chief Development Officer before GSK) |
Chief Medical Officer (CMO) |
Nabriva (Group) |
Austria |
| Princen, Marc (Takeda 201411– President Europe + Canada business unit before Merck + Schering-Plough) |
President/Director/Head Business Group/Unit/Division |
Takeda (Group) |
Switzerland |
| Priscoglio, Claudio (Cepheid 201304 Marketing Manager at Cepheid GmbH before BD) |
Sales Manager / Marketing Manager |
Danaher (Group) |
Germany |
| Pritchard, Randy (Roche 201211 VP Marketing at Roche Diagnostics Corp) |
Sales Manager / Marketing Manager |
Roche (Group) |
United States (USA) |
| Prokešová, Barbora (DataApex 201203) |
n. a. |
DataApex (CZ) |
Czech Republic |
| Proksch, Susanne (Spindiag 202005 Business Development + PR) |
Business Development Manager / Strategy Manager |
Spindiag GmbH |
Germany |
| Proll, Christiane (Numares 201612) |
Public Relations Manager / Investor Relations Manager |
Numares (Group) |
Germany |
| Proll, Günther (Biametrics GmbH 201105 Managing Director + Founder) |
Managing Director |
Biametrics GmbH |
Germany |
| Prüfer, Dirk (University of Munster 200808) |
n. a. |
University of Münster (Westfälische Wilhelms-Universität Münster) |
Germany |
| Przyborowski, Falko (Hansa Fine Chemicals 201212 Managing Director) |
Managing Director |
Hansa Fine Chemicals GmbH |
Germany |
| Przyborski, Stefan (Reinnervate 201207 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
ReproCell (Group) |
United Kingdom (GB) |
| Przybylski, Michael (Univ Konstanz 2009 Professor Analytical Chemistry) |
Professor |
University of Constance (Universität Konstanz) |
Germany |
| Pröll, Florian (Biametrics GmbH 201105 Managing Director + Founder) |
Managing Director |
Biametrics GmbH |
Germany |
| Pröschel, Michael (Galenica 201102 Managing Director of Vifor Pharma Deutschland GmbH) |
Managing Director |
Vifor Pharma (Group) |
Germany |
| Pucci, Paolo (ArQule 201912 CEO before Bayer Schering Pharma 200701) |
Chief Executive Officer (CEO) |
Merck (US) (MSD) (Group) |
United States (USA) |
| Puchta, Josef (Helmholtz 201810 Commerical Board Director at DKFZ) |
Chief Commercial Officer (CCO) |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Pugh, John (Boehringer Ingelheim 201204 Director of Digital) |
Public Relations Manager / Investor Relations Manager |
Boehringer Ingelheim (Group) |
Germany |
| Puig de Dou, Joan (Kymos 202009 CEO) |
Chief Executive Officer (CEO) |
Kymos (Group) |
Spain (España) |
| Pul, Ümit (BRAIN 201410– Project Leader CRSIPR before Univ Düsseldorf) |
Research & Development Manager |
BRAIN (Group) |
Germany |
| Puls, Michael (evocatal 201002 Managing Director / CMO) |
Managing Director |
Advanced Enzyme Technologies (Advanced Enzymes) (Group) |
Germany |
| Pultar, Thomas (Biomeva GmbH 201104 Managing Director) |
Managing Director |
Asahi Glass (AGC) (Group) |
Germany |
| Punnamootil, Beena (Chimera Biotec 201402– Managing Director) |
Managing Director |
Kompass (Group) |
Germany |
| Purkarthofer, Thomas (VTU Technology 201412 Head Business Development) |
Business Development Manager / Strategy Manager |
KonValue (Group) |
Austria |
| Pusch, Wolfgang (Bruker Daltonics 201808 EVP Microbiology + Diagnostics) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
| Puschmann, Till (CellGenix 202005 VP RnD + Business Development) |
Research & Development Manager |
CellGenix (Group) |
Germany |
| Putman, Jeff (Massa Investment AG 201906) |
Investment Manager |
Massa Investment AG |
Germany |
| Puttar, Thomas |
n. a. |
Asahi Glass (AGC) (Group) |
Germany |
| Putz, Pam (Informa 202003 Managing Director Europe of EBD Group) |
Managing Director |
Informa plc (Group) |
Germany |
| Puylaert, Kevin (Sophia Genetics 202002 VP Business Development) |
Business Development Manager / Strategy Manager |
Sophia Genetics (Group) |
Switzerland |
| Pühler, Alfred (Univ Bielefeld Prof) |
n. a. |
University of Bielefeld |
Germany |
| Pützer, Manfred (Omnilab (D) 200903 Managing Director) |
Managing Director |
Omnilab (DE) (Group) |
Germany |
| Pätz, Günther (Celares 201603 Managing Director) |
Managing Director |
Celares GmbH |
Germany |
| Pääbo, Svante (Max Planck 200805 MPI for Evolutionary Anthropology Leipzig) |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
| Pöhlchen, Martin (Sinfonie LS 201206– Managing Director before Revotar + SuppreMol + Pieris) |
Chief Executive Officer (CEO) |
Sinfonie Life Science Management GmbH |
Germany |
| Pöhlmann, Tobias (BianoScience GmbH 201203– Managing Director + Founder) |
Managing Director |
BianoScience GmbH |
Germany |
| Pöpping, Bert (FOCOS GbR 201703– Co-Owner before Mérieux NutriSciences + GROFOR + Eurofins) |
Research & Development Manager |
FOCOS GbR (FOCOS Food Consulting) – Dr. Bert Pöpping + Dr. Carmen Diaz-Amigo |
Germany |
| Pörtner, Ralf (TU Hamburg-Harburg 201109 Professor) |
Professor |
Technical University Hamburg-Harburg (TUHH) |
Germany |
| Pötting, Sierk (BioNTech 201409– CFO before Sandoz Inc/Novartis + McKinsey) |
Chief Financial Officer (CFO) |
BioNTech (Group) |
Germany |
| Pötz, Oliver (Signatope GmbH 201608– Managing Director + Co-Founder before Univ Tübingen Researcher at NMI) |
Researcher (university / research institute) |
Signatope GmbH |
Germany |
| Pötzsch, Jörg (RNAx GmbH 200604 CEO) |
Chief Executive Officer (CEO) |
RNAx GmbH |
Germany |
| Quandt, Achim (Qiagen 200905 Senior Global Product Manager) |
Product Manager (personnel) |
Qiagen (Group) |
Germany |
| Quennet-Thielen, Cornelia (Germany (govt) 200808 Secretary of State BMBF) |
n. a. |
Germany (govt) |
Germany |
| Questier, Bernard (Evotec OAI 200310–200408) |
n. a. |
Evotec (Group) |
Germany |
| Quinn, Dan (Ten Bridge Communications 201612 CEO + Co-Founder before Feinstein Kean Healthcare + Genzmye) |
Chief Executive Officer (CEO) |
Ten Bridge Communications (US) |
United States (USA) |
| Quirk, Robin (Locate Therapeutics Ltd 201412 Executive Director) |
Chief Executive Officer (CEO) |
Locate Bio Ltd. |
United Kingdom (GB) |
| Raab, Martin (Endress+Hauser 201604 Head Public + Internal Communication) |
Public Relations Manager / Investor Relations Manager |
Endress+Hauser (Group) |
Switzerland |
| Rabbe, Anders (Isofol Medical AB 201502 Managing Director) |
Managing Director |
Isofol Medical AB |
Sweden |
| Rabini, Johannes (Sobera Capital 2010– Managing Director + Co-Founder before Triginta Capital) |
Managing Director |
Sobera Capital GmbH |
Germany |
| Rabinowitz, Matthew (Natera Inc 201302 CEO) |
Chief Executive Officer (CEO) |
Natera Inc. (Nasdaq: NTRA) |
United States (USA) |
| Rabus, Werner W. |
n. a. |
Eisenführ Speiser Patentanwälte Rechtsanwälte PartGmbB |
Germany |
| Rachel, Thomas (BMBF 200709 Staatssekretär) |
n. a. |
Germany (govt) |
Germany |
| Radakovic, Stojan (Ako med d.o.o. 201310 Director) |
President/Director/Head Business Group/Unit/Division |
Ako med d.o.o. |
Serbia |
| Radic, Christofer (Nanohale 201111 IR + PR Manager) |
Public Relations Manager / Investor Relations Manager |
Formycon (Group) |
Germany |
| Raditsch, Martin (Univ Frankfurt 202003 CEO of Innovectis) |
Chief Executive Officer (CEO) |
University of Frankfurt (Goethe-Universität) |
Germany |
| Radvanyi, Laszlo (Merck (DE) 201511– Head of Global Immuno-oncology Research before CSO at Lion Biotechnologies) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Merck (DE) (Group) |
Germany |
| Raem, Arnold Maria (Arrows Biomedical Deutschland GmbH 201408 Managing Director) |
Managing Director |
Arrows Biomedical (Group) |
Germany |
| Raetzman, Stuart (Alcon 201101 VP Global Marketing + General Manager US Business) |
Sales Manager / Marketing Manager |
Novartis (Group) |
Switzerland |
| Raffensperger, Alan (Sobi 201201– COO before Benechill + Amgen + Roche + Boehringer Mannheim + Pharmacia) |
Chief Operating Officer (COO) |
Swedish Orphan Biovitrum (Sobi) (Group) |
Sweden |
| Rafigh, Mehran (Sartorius 201309 Business Development Manager before HTGF Investment Manager) |
Business Development Manager / Strategy Manager |
Sartorius (Group) |
Germany |
| Ragab, Mohamed (iTeos Therapeutics 201706– VP Corp Development before BMS + Roche + Pfizer + Ortho Biotech) |
Business Development Manager / Strategy Manager |
iTeos Therapeutics (Group) |
Belgium |
| Ragan, Paula (X4 Pharmaceuticals 201811 CEO) |
Chief Executive Officer (CEO) |
X4 Pharmaceuticals (Group) |
United States (USA) |
| Ragotzky, Klaus (Fidura 202011 Managing Director + Chairman of Advisory Board) |
Managing Director |
Fidura Private Equity Fonds (Group) |
Germany |
| Rajathurai, Arnold (Bayer Technology Systems 200503) |
n. a. |
Bayer (Group) |
Germany |
| Rajewsky, Klaus (Harvard Univ 2002– before Univ Cologne) |
n. a. |
Harvard University |
United States (USA) |
| Rajmann, Britta |
n. a. |
Wiley (Group) |
Germany |
| Ralser, Markus (Francis Crick Institute 201606 before Univ Cambridge 201310) |
mass spectrometry (MS) |
Francis Crick Institute Ltd., The |
United Kingdom (GB) |
| Ramachandra, Murah (Aurigene 201306 SVP Preclinical Biology) |
Research & Development Manager |
Dr. Reddy’s (Group) |
India |
| Raman, Prakash (Flagship Pioneering 201911– Senior Partner + Chief BusDev Officer before Novartis NIBR + AstraZeneca) |
Partner (venture partner) |
Flagship Pioneering |
United States (USA) |
| Ramaswamy, Vivek (Roivant Sciences 201708 CEO + Founder) |
Chief Executive Officer (CEO) |
Roivant (Group) |
Switzerland |
| Rambeaux, Eric (MyoPowers 210506 CEO) |
Chief Executive Officer (CEO) |
MyoPowers Medical Technologies France S.A.S. |
France |
| Ramdahl, Thomas (Algeta 201308– COO before CTO before CEO since 2001) |
Chief Operating Officer (COO) |
Bayer (Group) |
Norway |
| Ramesh, R. (Medi Analytika India 201505 Managing Director) |
Managing Director |
Medi Analytika India Pvt. Ltd. |
India |
| Rampf, Stefan (Rentschler 201605–2020006 CFO before ABL Technik Entlackung GmbH + Volvo Financial Services LEFT 6/20) |
Chief Financial Officer (CFO) |
Rentschler (Group) |
Germany |
| Ramroth, Michael (Biotest 201301 CFO) |
Chief Financial Officer (CFO) |
Creat (Group) |
Germany |
| Ramsay, John (Syngenta 200707– CFO) |
Chief Financial Officer (CFO) |
Syngenta (Group) |
Switzerland |
| Rando, Jason (Tiberend Strategic Advisors 201707 EVP + COO) |
Chief Operating Officer (COO) |
Tiberend Strategic Advisors (NY) |
United States (USA) |
| Rang, Harald (BASF 201707 SVP Global RnD Crop Protection) |
Research & Development Manager |
BASF (Group) |
Germany |
| Rant, Ulrich (Dynamic Biosensors GmbH 201301 Managing Director (CEO) + Founder) |
Managing Director |
Dynamic Biosensors (Group) |
Germany |
| Rao, Venkat (Sartorius 201902 Head Business Management, EMEA Life Science Research) |
Business Development Manager / Strategy Manager |
Sartorius (Group) |
Germany |
| Rapp, Stephan (Neuway Pharma GmbH 20140–201508 Managing Director) |
Managing Director |
Neuway Pharma GmbH |
Germany |
| Rapp, Ulf R. (Universität Würzburg 200504) |
n. a. |
University of Würzburg |
Germany |
| Raquet, Line Stigen (Creoptix 202001– CEO before Mettler-Toledo + Qiagen) |
Chief Executive Officer (CEO) |
Creoptix AG |
Switzerland |
| Rasche, Michael (AstraZeneca 201707– promoted CCO at Definiens joined 201602 as SVP Global Sales before Ayoxxa + Dako) |
Chief Commercial Officer (CCO) |
AstraZeneca (Group) |
Germany |
| Rasche, Thom (Earlybird 200809 Partner) |
Partner (venture partner) |
Earlybird (Group) |
Germany |
| Rascher-Eggstein, Gesa (Nanion Technologies 201607– Marketing Director before Anaxon + Axiogenesis + Cytocentrics) |
n. a. |
Nanion (Group) |
Germany |
| Raschke, Eva |
n. a. |
Thermo Fisher (Group) |
Germany |
| Raschke, Fabian (Grünenthal 201902– CFO joined 201609 before Xella Group) |
Chief Financial Officer (CFO) |
Grünenthal (Group) |
Germany |
| Rasi, Guido (EMA 201111– Executive Director) |
Administrative Officer (personnel) |
EU (govt) |
Netherlands |
| Rasmus, Conrad (Protembis GmbH 2013– Managing Director + Co-Founder) |
Managing Director |
Protembis GmbH |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 51 52 53 ... 73 74 75 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
